|
CH449645A
(de)
|
1963-07-09 |
1968-01-15 |
Ciba Geigy |
Verfahren zur Herstellung neuer Aminosäuren
|
|
JPS4940460Y2
(enExample)
|
1971-05-19 |
1974-11-06 |
|
|
|
US4087544A
(en)
|
1974-12-21 |
1978-05-02 |
Warner-Lambert Company |
Treatment of cranial dysfunctions using novel cyclic amino acids
|
|
DE2460891C2
(de)
|
1974-12-21 |
1982-09-23 |
Gödecke AG, 1000 Berlin |
1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
US4123438A
(en)
|
1975-03-05 |
1978-10-31 |
Stamicarbon, B.V. |
Process for preparing 2-pyrrolidones
|
|
NZ194348A
(en)
|
1979-07-26 |
1982-09-14 |
Merrell Toraude & Co |
Fluorinated methyl-beta-alanine derivatives and pharmaceutical compositions
|
|
US4322440A
(en)
|
1980-06-25 |
1982-03-30 |
New York University |
Anticonvulsive compositions and method of treating convulsive disorders
|
|
US4513135A
(en)
|
1982-03-05 |
1985-04-23 |
Eli Lilly And Company |
Diaryl-pyrazine derivatives affecting GABA binding
|
|
DK373383A
(da)
|
1982-08-20 |
1984-02-21 |
Midit |
Fremgangsmaade til fremstilling af omega-aminosyrederivater
|
|
US4479005A
(en)
|
1982-12-16 |
1984-10-23 |
The Dow Chemical Company |
Selective preparation of isomers and enantiomers of cyclopropane carboxylic acids
|
|
DE3476197D1
(en)
|
1983-08-01 |
1989-02-23 |
Mclean Hospital Corp |
Gaba esters and gaba analogue esters
|
|
US5051448A
(en)
|
1984-07-24 |
1991-09-24 |
The Mclean Hospital Corporation |
GABA esters and GABA analog esters
|
|
GB8425872D0
(en)
|
1984-10-12 |
1984-11-21 |
Ciba Geigy Ag |
Chemical compounds
|
|
DK170473B1
(da)
|
1985-06-20 |
1995-09-11 |
Daiichi Seiyaku Co |
S(-)-pyridobenzoxazinforbindelser
|
|
US4956388A
(en)
|
1986-12-22 |
1990-09-11 |
Eli Lilly And Company |
3-aryloxy-3-substituted propanamines
|
|
JP2535001B2
(ja)
|
1987-01-13 |
1996-09-18 |
ダイセル化学工業株式会社 |
Ｎ−アルキル化アミノ酸エステルの製法
|
|
JPH07116064B2
(ja)
|
1987-07-21 |
1995-12-13 |
三菱化学株式会社 |
分離剤
|
|
US4908210A
(en)
|
1988-10-28 |
1990-03-13 |
Eastman Kodak Company |
Lactylic salt tablet formulations and tablets
|
|
GB8911017D0
(en)
|
1989-05-13 |
1989-06-28 |
Ciba Geigy Ag |
Substituted aminoalkylphosphinic acids
|
|
DE3928183A1
(de)
|
1989-08-25 |
1991-02-28 |
Goedecke Ag |
Lactamfreie cyclische aminosaeuren
|
|
GB8921304D0
(en)
|
1989-09-20 |
1989-11-08 |
Wyeth John & Brother Ltd |
New method of treatment and heterocyclic compounds used therein
|
|
US5104869A
(en)
|
1989-10-11 |
1992-04-14 |
American Cyanamid Company |
Renin inhibitors
|
|
US5084479A
(en)
|
1990-01-02 |
1992-01-28 |
Warner-Lambert Company |
Novel methods for treating neurodegenerative diseases
|
|
US5025035A
(en)
|
1990-10-12 |
1991-06-18 |
Warner-Lambert Company |
Method of treating depression
|
|
US6197819B1
(en)
|
1990-11-27 |
2001-03-06 |
Northwestern University |
Gamma amino butyric acid analogs and optical isomers
|
|
AU9137091A
(en)
|
1990-11-27 |
1992-06-25 |
Northwestern University |
Gaba and l-glutamic acid analogs for antiseizure treatment
|
|
WO1992014443A1
(en)
|
1991-02-20 |
1992-09-03 |
Warner-Lambert Company |
Microsphere-in-oil emulsion
|
|
DK204791D0
(da)
|
1991-12-20 |
1991-12-20 |
Novo Nordisk As |
Hidtil ukendt farmaceutisk praeparat
|
|
HU222776B1
(hu)
*
|
1992-05-20 |
2003-10-28 |
Northwestern University |
(S)-(+)-4-amino-3-(2-metil-propil)-butánsav előállításának új hexánsav- és butándisav-származék köztitermékei és ezek előállítása
|
|
GB9308430D0
(en)
|
1993-04-23 |
1993-06-09 |
Glaxo Group Ltd |
Medicaments
|
|
US5492927A
(en)
|
1993-12-21 |
1996-02-20 |
Eli Lilly And Company |
Non-peptide tachykinin receptor antagonists to treat allergy
|
|
US5652216A
(en)
|
1994-05-26 |
1997-07-29 |
Novo Nordisk A/S |
Pharmaceutical preparation
|
|
AU703428B2
(en)
|
1994-07-27 |
1999-03-25 |
Warner-Lambert Company |
Use of gabapentin in the treatment of anxiety and panic
|
|
US5792796A
(en)
|
1994-07-27 |
1998-08-11 |
Warner-Lambert Company |
Methods for treating anxiety and panic
|
|
GB9420784D0
(en)
|
1994-10-14 |
1994-11-30 |
Glaxo Group Ltd |
Medicaments
|
|
US5767117A
(en)
|
1994-11-18 |
1998-06-16 |
The General Hospital Corporation |
Method for treating vascular headaches
|
|
EP0802912B1
(en)
|
1995-01-12 |
2004-10-13 |
Glaxo Group Limited |
Piperidine derivatives having tachykinin antagonist activity
|
|
EE03483B1
(et)
|
1995-02-28 |
2001-08-15 |
H. Lundbeck A/S |
4-aminotetrahüdrobensisoksasooli või -isotiasooli ühendid, nende kasutamine farmatseutiliste preparaatide valmistamiseks ja nimetatud ühendeid sisaldavad farmatseutilised kompositsioonid
|
|
US5510381A
(en)
|
1995-05-15 |
1996-04-23 |
Warner-Lambert Company |
Method of treatment of mania and bipolar disorder
|
|
US5616793A
(en)
|
1995-06-02 |
1997-04-01 |
Warner-Lambert Company |
Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid
|
|
US5637767A
(en)
|
1995-06-07 |
1997-06-10 |
Warner-Lambert Company |
Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid
|
|
US5929088A
(en)
|
1996-02-07 |
1999-07-27 |
Warner-Lambert Company |
Cyclic amino acids as pharmaceutical agents
|
|
UA49011C2
(uk)
|
1996-03-14 |
2002-09-16 |
Варнер-Ламберт Компані |
Похідні циклічної амінокислоти, фармацевтична композиція та спосіб лікування
|
|
US6020370A
(en)
|
1996-03-14 |
2000-02-01 |
Warner-Lambert Company |
Bridged cyclic amino acids as pharmaceutical agents
|
|
US20020077461A1
(en)
|
1996-04-24 |
2002-06-20 |
Soren Bjorn |
Pharmaceutical formulation
|
|
US6372792B1
(en)
|
1996-04-26 |
2002-04-16 |
Guy Chouinard |
Method for treating anxiety, anxiety disorders and insomnia
|
|
WO1997049393A1
(en)
|
1996-06-26 |
1997-12-31 |
Warner-Lambert Company |
Use of a tachykinin antagonist for the manufacture of a medicament for the treatment of emesis
|
|
SE9603408D0
(sv)
|
1996-09-18 |
1996-09-18 |
Astra Ab |
Medical use
|
|
HRP980342A2
(en)
|
1997-06-25 |
1999-02-28 |
Warner Lambert Co |
Anti-inflammatory method
|
|
US6329429B1
(en)
|
1997-06-25 |
2001-12-11 |
Warner-Lambert Company |
Use of GABA analogs such as Gabapentin in the manufacture of a medicament for treating inflammatory diseases
|
|
US6194459B1
(en)
|
1997-08-19 |
2001-02-27 |
Warner-Lambert Company |
Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotors stimulants
|
|
US6127418A
(en)
|
1997-08-20 |
2000-10-03 |
Warner-Lambert Company |
GABA analogs to prevent and treat gastrointestinal damage
|
|
WO1999008670A1
(en)
|
1997-08-20 |
1999-02-25 |
Guglietta, Antonio |
Gaba analogs to prevent and treat gastrointestinal damage
|
|
JP3782935B2
(ja)
|
1997-09-08 |
2006-06-07 |
ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー |
抗癲癇化合物を含有する鎮痛剤組成物およびその使用方法
|
|
DK1045839T3
(da)
|
1997-12-16 |
2004-07-05 |
Warner Lambert Co |
Hidtil ukendte aminer som farmaceutiske midler
|
|
CA2327285C
(en)
|
1998-05-15 |
2005-06-14 |
Warner-Lambert Company |
Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
|
|
ID26395A
(id)
|
1998-05-15 |
2000-12-21 |
Warner Lambert Comapny |
Turunan asam gamma-aminobutirat yang mengandung komposisi padat dan proses pembuatannya
|
|
US6680343B1
(en)
|
1998-07-09 |
2004-01-20 |
Warner-Lambert Comapny |
Treatment of renal colic with GABA analogs
|
|
EP1094817A1
(en)
|
1998-07-09 |
2001-05-02 |
Warner-Lambert Company |
Compositions comprising gaba analogs and caffeine
|
|
US20030045500A1
(en)
|
1998-07-09 |
2003-03-06 |
Leslie Magnus |
Pharmaceutical composition containing GABA analogs and an antiviral agent to treat shingles
|
|
JP2002520277A
(ja)
|
1998-07-09 |
2002-07-09 |
ワーナー−ランバート・カンパニー |
不眠症を治療する方法
|
|
EP1121114B1
(en)
|
1998-10-16 |
2007-01-10 |
Warner-Lambert Company Llc |
Use of gaba analogs for the manufacture of a medicament for the treatment of mania and bipolar disorders
|
|
US6451857B1
(en)
|
1999-03-10 |
2002-09-17 |
Warner-Lambert Company |
Analgesic compositions comprising anti-epileptic compounds and methods of using same
|
|
US6992109B1
(en)
|
1999-04-08 |
2006-01-31 |
Segal Catherine A |
Method for the treatment of incontinence
|
|
NZ514401A
(en)
|
1999-04-09 |
2003-10-31 |
Warner Lambert Co |
Combinations of GABA analogs and tricyclic compounds to treat depression
|
|
BR0011236A
(pt)
|
1999-06-02 |
2002-03-05 |
Warner Lambert Co |
Amino heterociclos úteis como agentes farmacêuticos
|
|
US7164034B2
(en)
|
1999-06-10 |
2007-01-16 |
Pfizer Inc. |
Alpha2delta ligands for fibromyalgia and other disorders
|
|
US6642398B2
(en)
|
1999-06-10 |
2003-11-04 |
Warner-Lambert Company |
Mono-and disubstituted 3-propyl gamma-aminobutyric acids
|
|
DE60024995T2
(de)
|
1999-07-02 |
2006-06-22 |
Warner-Lambert Co. Llc |
Synergistische kombination: gabapentin und pregabalin
|
|
US7030119B1
(en)
|
1999-07-16 |
2006-04-18 |
Warner-Lambert Company |
Method for treating chronic pain using MEK inhibitors
|
|
EP1214599A2
(en)
|
1999-09-16 |
2002-06-19 |
Warner-Lambert Company |
Screening for alpha2delta-1 subunit binding ligands
|
|
AP2002002501A0
(en)
|
1999-10-07 |
2002-06-30 |
Warner Lambert Co |
Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog.
|
|
BRPI0107863B8
(pt)
|
2000-01-27 |
2017-04-25 |
Warner-Lambert Company |
método para preparar um derivado do ácido (s)-3- ciano-5-metilhexanoico, composto intermediário, seu método de preparação e método para preparar a pregabalina
|
|
US20010036943A1
(en)
|
2000-04-07 |
2001-11-01 |
Coe Jotham W. |
Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
|
|
EP1294854A2
(en)
|
2000-05-16 |
2003-03-26 |
Warner-Lambert Company |
Cell line for the expression of an alpha2-delta2 calcium channel subunit
|
|
GB2365425A
(en)
|
2000-08-01 |
2002-02-20 |
Parke Davis & Co Ltd |
Alkyl amino acid derivatives useful as pharmaceutical agents
|
|
CA2356829A1
(en)
|
2000-09-22 |
2002-03-22 |
Warner-Lambert Company |
Method for treating asthma using pregabalin
|
|
US6620829B2
(en)
|
2000-10-17 |
2003-09-16 |
Warner-Lambert Company |
Method of treating noninflammatory cartilage damage
|
|
WO2002043763A2
(en)
|
2000-11-30 |
2002-06-06 |
Pfizer Products Inc. |
Combination of gaba agonists and aldose reductase inhibitors
|
|
CA2430298A1
(en)
|
2000-11-30 |
2002-06-06 |
Banavara Lakshman Mylari |
Combination of gaba agonists and sorbitol dehydrogenase inhibitors
|
|
WO2002048161A1
(en)
|
2000-12-13 |
2002-06-20 |
Warner-Lambert Company Llc |
P-chirale bisphospholane ligands, their transition metal complexes
|
|
US20040002543A1
(en)
|
2001-02-16 |
2004-01-01 |
Leslie Magnus |
Compositions comprising GABA analogs and a decongestant to relieve sinus headache pain
|
|
ATE297902T1
(de)
|
2001-02-28 |
2005-07-15 |
Pfizer Prod Inc |
Sulfonyl-pyridazinon-derivate zur verwendung als aldose-reduktase-inhibitoren
|
|
MXPA02001147A
(es)
|
2001-03-19 |
2004-04-21 |
Warner Lambert Co |
Sintesis de ligandos bisfosina no-c2-simetricos como catalizadores para la hidrogenacion asimetrica.
|
|
US7022678B2
(en)
|
2001-03-30 |
2006-04-04 |
Warner-Lambert Company |
Pregabalin lactose conjugates
|
|
EP1491541B1
(en)
|
2001-03-30 |
2007-01-24 |
Pfizer Products Inc. |
Pyridazinone aldose reductase inhibitors
|
|
EP1247809A3
(en)
|
2001-03-30 |
2003-12-17 |
Pfizer Products Inc. |
Triazine compounds useful as sorbitol dehydrogenase inhibitors
|
|
BR0208922A
(pt)
|
2001-04-19 |
2004-04-20 |
Warner Lambert Co |
Aminoácidos bicìclicos ou tricìclicos fundidos
|
|
DE60213592T2
(de)
|
2001-05-25 |
2007-08-09 |
Warner-Lambert Co. Llc |
Flüssige pharmazeutische zusammensetzung
|
|
US20030045449A1
(en)
|
2001-08-15 |
2003-03-06 |
Pfizer, Inc. |
Pharmaceutical combinations for the treatment of neurodegenerative diseases
|
|
DE10203122A1
(de)
|
2002-01-25 |
2003-07-31 |
Gruenenthal Gmbh |
Verfahren zur Herstellung von substituierten Acrylsäureestern bzw. deren Einsatz zur Herstellung von substituierten gamma-Aminosäuren
|
|
CN1625393A
(zh)
|
2002-01-31 |
2005-06-08 |
沃纳-兰伯特公司 |
治疗耳鸣的α2δ配体
|
|
US6855724B2
(en)
|
2002-04-08 |
2005-02-15 |
Agouron Pharmaceuticals, Inc. |
Tropane derivatives useful in therapy
|
|
US6713490B2
(en)
|
2002-04-26 |
2004-03-30 |
Pfizer, Inc. |
3,4-dihydroquinolin-2(1H)-one compounds as NR2B receptor antagonists
|
|
US20030225149A1
(en)
|
2002-04-30 |
2003-12-04 |
Blazecka Peter G. |
Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids
|
|
WO2004002462A2
(en)
|
2002-06-27 |
2004-01-08 |
Warner-Lambert Company Llc |
Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder
|
|
JP4503436B2
(ja)
|
2002-07-08 |
2010-07-14 |
ファイザー・プロダクツ・インク |
糖質コルチコイド受容体のモジュレーター
|
|
US7053122B2
(en)
|
2002-08-09 |
2006-05-30 |
Pfizer Inc |
Therapeutic use of aryl amino acid derivatives
|
|
US7419981B2
(en)
|
2002-08-15 |
2008-09-02 |
Pfizer Inc. |
Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
|
|
US20040092522A1
(en)
|
2002-08-15 |
2004-05-13 |
Field Mark John |
Synergistic combinations
|
|
US7071339B2
(en)
|
2002-08-29 |
2006-07-04 |
Warner Lambert Company Llc |
Process for preparing functionalized γ-butyrolactones from mucohalic acid
|
|
US7659305B2
(en)
|
2002-10-31 |
2010-02-09 |
Pfizer Inc. |
Therapeutic proline derivatives
|
|
WO2004052373A1
(en)
|
2002-12-06 |
2004-06-24 |
Warner-Lambert Company Llc |
Benzoxazin-3-ones and derivatives thereof as inhibitors of pi3k
|
|
CA2451267A1
(en)
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Pharmaceutical uses for alpha2delta ligands
|
|
EP1572187A1
(en)
|
2002-12-13 |
2005-09-14 |
Warner-Lambert Company LLC |
Pregabalin and derivatives thereof for the treatment of fibromyalgia and other related disorders
|
|
US7572910B2
(en)
|
2003-02-20 |
2009-08-11 |
Pfizer, Inc. |
Pyridazinone aldose reductase inhibitors
|
|
CA2525366A1
(en)
|
2003-05-16 |
2004-11-25 |
Pfizer Products Inc. |
Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines
|
|
EP1644360A1
(en)
|
2003-06-05 |
2006-04-12 |
Warner-Lambert Company LLC |
3-substituted indoles and derivatives thereof as therapeutic agents
|
|
WO2005002585A1
(en)
|
2003-07-02 |
2005-01-13 |
Warner-Lambert Company Llc |
Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
|
|
UA86204C2
(uk)
|
2003-09-03 |
2009-04-10 |
Пфайзер Инк. |
Сполуки бензімідазолону, які мають 5-нт4 рецепторну агоністичну активність
|
|
JP2007505095A
(ja)
|
2003-09-12 |
2007-03-08 |
ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー |
うつ病及び不安障害の治療のためのアルファ−２−デルタリガンド及びｓｓｒｉ及び／又はｓｎｒｉを含む組み合わせ
|
|
AU2004271800A1
(en)
|
2003-09-12 |
2005-03-24 |
Pfizer Inc. |
Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
|
|
GB0322140D0
(en)
|
2003-09-22 |
2003-10-22 |
Pfizer Ltd |
Combinations
|
|
EP1670750A1
(en)
|
2003-09-25 |
2006-06-21 |
Warner-Lambert Company LLC |
Prodrugs of amino acids with affinity for the alpha2delta- protein
|
|
US7572799B2
(en)
|
2003-11-24 |
2009-08-11 |
Pfizer Inc |
Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
|
|
EP1543831A1
(en)
|
2003-12-18 |
2005-06-22 |
Pfizer GmbH Arzneimittelwerk Gödecke |
Pregabalin composition
|
|
WO2005082372A1
(en)
|
2004-01-29 |
2005-09-09 |
Pfizer Products Inc. |
COMBINATION OF γ-AMINOBUTYRIC ACID MODULATORS AND 5-HT 1B RECEPTOR ANTAGONISTS
|
|
GB0405200D0
(en)
|
2004-03-08 |
2004-04-21 |
Pfizer Ltd |
Combinations comprising alpha-2-delta ligands
|
|
ES2292107T3
(es)
|
2004-03-12 |
2008-03-01 |
Warner-Lambert Company Llc |
Ligandos de bifosfina simetricos en c1 y su uso en la sintesis asimetrica de pregabalina.
|
|
US7354925B2
(en)
|
2004-03-29 |
2008-04-08 |
Pfizer Inc. |
Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as ORL1-receptor antagonists
|
|
EP1735324B1
(en)
|
2004-04-01 |
2008-08-20 |
Warner-Lambert Company LLC |
Preparation of p-chirogenic phospholanes and their use in asymetric synthesis
|
|
CA2562251C
(en)
|
2004-04-07 |
2009-04-28 |
Pfizer Inc. |
Pyrazolo'4,3-d pyrimidines
|
|
UA82292C2
(uk)
|
2004-04-14 |
2008-03-25 |
Пфайзер Продактс Инк. |
Спосіб стереоселективного біоперетворення аліфатичних динітрилів в ціанокарбонові кислоти (варіанти)
|
|
MXPA06011891A
(es)
|
2004-04-20 |
2007-04-24 |
Pfizer |
Metodo para tratar el dolor neuropatico.
|
|
WO2005102389A2
(en)
|
2004-04-20 |
2005-11-03 |
Pfizer Products Inc. |
Combinations comprising alpha-2-delta ligands and ep4 receptor antagonists
|
|
WO2005102390A2
(en)
|
2004-04-22 |
2005-11-03 |
Pfizer Japan, Inc. |
Combinations comprising alpha-2-delta ligands and nmda receptor antagonists
|
|
JP4185154B2
(ja)
|
2004-04-30 |
2008-11-26 |
ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー |
中枢神経系障害治療用の置換モルホリン化合物
|
|
US7737163B2
(en)
|
2004-06-15 |
2010-06-15 |
Pfizer Inc. |
Benzimidazolone carboxylic acid derivatives
|
|
CA2569654C
(en)
|
2004-06-15 |
2010-12-21 |
Pfizer Inc. |
Benzimidazolone carboxylic acid derivatives
|
|
HRP20100054T1
(hr)
|
2004-06-21 |
2010-05-31 |
Warner-Lambert Company Llc |
Dobivanje pregabalina i njemu sličnih spojeva
|
|
WO2006003500A1
(en)
|
2004-06-29 |
2006-01-12 |
Pfizer Products Inc. |
Method for preparing 5-`4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3h`1,2,4!triazin-2-yl!-benzamide derivatives by deprotecting the hydroxyl-protected precursers
|
|
US20060003344A1
(en)
|
2004-06-30 |
2006-01-05 |
Pfizer Inc. |
Methods related to a single nucleotide polymorphism of the G protein coupled receptor, GPR40
|
|
WO2006008640A1
(en)
|
2004-07-15 |
2006-01-26 |
Pharmacia & Upjohn Company Llc |
Non-aqueous suspension containing a drug having an unpleasant taste
|
|
AU2005266090A1
(en)
|
2004-07-23 |
2006-02-02 |
Pfizer Inc. |
Pyridine derivatives
|
|
GB0419849D0
(en)
|
2004-09-07 |
2004-10-13 |
Pfizer Ltd |
Pharmaceutical combination
|
|
ES2318556T3
(es)
|
2004-11-02 |
2009-05-01 |
Pfizer, Inc. |
Derivados de sulfonil bencimidazol.
|
|
CN101087771A
(zh)
|
2004-11-10 |
2007-12-12 |
辉瑞大药厂 |
经取代n－磺酰基氨基苄基－2－苯氧基乙酰胺化合物
|
|
US7122683B2
(en)
|
2004-11-23 |
2006-10-17 |
Pfizer Inc. |
Amides useful as monoamine re-uptake inhibitors
|
|
KR20070094747A
(ko)
|
2004-11-29 |
2007-09-21 |
워너-램버트 캄파니 엘엘씨 |
치료용 피라졸로［３,４-ｂ］피리딘 및 인다졸
|
|
KR100908547B1
(ko)
|
2005-02-22 |
2009-07-20 |
화이자 인코포레이티드 |
５ｈｔ４ 수용체 작용제로서의 옥시인돌 유도체
|
|
WO2006092692A1
(en)
|
2005-03-01 |
2006-09-08 |
Pfizer Limited |
Use of combinations of pde7 inhibitors and alpha-2-delty ligands for the treatment of neuropathic pain
|
|
ES2331153T3
(es)
|
2005-03-10 |
2009-12-22 |
Pfizer Inc. |
Compuestos de n-sulfonilaminofeniletil-2-fenoxiacetamida sustituidos.
|
|
EA200701745A1
(ru)
|
2005-03-17 |
2008-06-30 |
Пфайзер, Инк. |
Циклопропанкарбоксамидные производные
|
|
EP1874732A1
(en)
|
2005-04-20 |
2008-01-09 |
Pfizer Limited |
Pyrazole derivatives as progesterone receptor antagonists
|
|
BRPI0609879A2
(pt)
|
2005-04-28 |
2010-05-11 |
Pfizer Ltd |
derivados de aminoácidos
|
|
BRPI0610316A2
(pt)
|
2005-05-20 |
2010-06-15 |
Pfizer Ltd |
combinações sinergìsticas de medicamentos atiinflamatórios não estereoidais com alfa-delta-ligantes
|
|
EP1893583B1
(en)
|
2005-05-31 |
2012-04-04 |
Pfizer Inc. |
Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists
|
|
NL2000281C2
(nl)
|
2005-11-02 |
2007-08-07 |
Pfizer Prod Inc |
Vaste farmaceutische samenstellingen die pregabaline bevatten.
|
|
NL2000284C2
(nl)
|
2005-11-04 |
2007-09-28 |
Pfizer Ltd |
Pyrazine-derivaten.
|
|
CN101304974A
(zh)
|
2005-11-08 |
2008-11-12 |
辉瑞有限公司 |
吡唑衍生物和它们的医药用途
|
|
RS20080233A
(sr)
|
2005-12-02 |
2009-07-15 |
Pfizer Limited, |
Derivati spirocikličnog hinazolina kao inhibitori pde7
|
|
CA2530904C
(en)
|
2005-12-20 |
2013-10-08 |
John Marino |
Pharmaceutical agents for the treatment of pain associated with spinal cord injury
|
|
AU2007222112A1
(en)
|
2006-03-06 |
2007-09-13 |
Pfizer Products Inc. |
Alpha-2-delta ligands for non-restorative sleep
|
|
GB0700786D0
(en)
|
2007-01-15 |
2007-02-21 |
Pfizer Ltd |
Morpholine dopamine agonists for the treatment of pain
|
|
HRP20110702T1
(hr)
|
2007-02-02 |
2011-10-31 |
Pfizer Products Inc. |
Triciklički spojevi i njihova uporaba kao modulatora glukokortikoidnih receptora
|
|
WO2008132589A1
(en)
|
2007-05-01 |
2008-11-06 |
Pfizer Limited |
Combinations comprising pregabalin
|